Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan

Inclusion Criteria: * Newly diagnosed Chronic Myeloid Leukemia in the Chronic Phase * 20 years old over * ECOG performance status (PS) score 0-2 * Adequate organ function (hepatic, renal and lung) * Signed written informed consent Exclusion Criteria: * A case with the double cancer of the activity * Women who are pregnant or breastfeeding * The case of Pleural effusion clearly * Patients with complications or a history of severe or uncontrolled cardiovascular failure following * have a Myocardial infarction whithin 6 months * have an Angina within 3 months * have a Congestive heart failure within 3 months * have a QTc interval of more than 450msec at baseline * A serious uncontrolled medical disorder that would impair the ability of the subjects to receive protocol therapy